Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J, Rallybio partner on drug development for rare fetal condition
BioPharma Dive
Wed, 04/10/24 - 06:01 pm
Tags:
JNJ, Rallybio, FNAIT, drug development
7 Billion-Dollar Oncology M&As from Q1
BioSpace
Wed, 04/10/24 - 11:24 am
Tags:
oncology, M&A, AbbVie, Immunogen, Bristol Myers Squibb, Mirati Therapeutics, RayzeBio, Novartis, MorphoSys, AstraZeneca, Fusion Pharmaceuticals, JNJ, Ambrx, Gracell
J&J scoops up cardio medtech Shockwave Medical for $13.1B
Medical Marketing and Media
Fri, 04/5/24 - 11:54 am
Tags:
JNJ, M&A, Medtech, Shockwave Medical, Cardiovascular, intravascular lithotripsy
Fierce Biotech's Quarterly IPO and M&A Roundup: Q1'24
Fierce Biotech
Wed, 04/3/24 - 11:36 am
Tags:
biotech, M&A, IPOs, CG Oncology, Kyverna Therapeutics, Contineum Therapeutics, Boundless Bio, CymaBay Therapeutics, Gilead Sciences, MorphoSys, Novartis, Fusion Pharmaceuticals, AstraZeneca, Ambryx, JNJ, Inhibrix, Aventis
J&J targets rare maternal-fetal diseases: 'We're going for this. No one else has.'
Fierce Biotech
Tue, 04/2/24 - 11:49 am
Tags:
JNJ, rare disease, maternal-fetal diseases, FNAIT, nipocalimab
Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
Reuters
Mon, 04/1/24 - 12:04 pm
Tags:
Teva Pharmaceutical, JNJ, Viatris, schizophrenia, patents, Invega Sustenna
J&J can contest evidence linking its talc to cancer, US judge rules
Reuters
Thu, 03/28/24 - 11:14 am
Tags:
JNJ, legal, talc, ovarian cancer
J&J Wins FDA Nod for Pulmonary Arterial Hypertension Combo Pill
BioSpace
Mon, 03/25/24 - 11:24 am
Tags:
JNJ, FDA, PAH, Opsynvi, macitentan, tadalafil
J&J's Abiomed sees serious Impella recall linked to heart perforations, 49 deaths
Fierce Biotech
Fri, 03/22/24 - 10:54 am
Tags:
JNJ, Abiomed, Medtech, Impella, patient deaths, device recalls
Idorsia's Tryvio crosses FDA finish line, offering new mechanism to treat hypertension
Fierce Pharma
Wed, 03/20/24 - 09:49 pm
Tags:
JNJ, Idorsia, Tryvio, hypertension, FDA
J&J alleges ex-staffer downloaded thousands of files in move to Pfizer
Seeking Alpha
Wed, 03/20/24 - 11:48 am
Tags:
JNJ, Pfizer, legal, trade secrets
Despite early death concerns, FDA advisers back J&J and Legend's Carvykti and BMS' Abecma for earlier myeloma
Fierce Pharma
Sun, 03/17/24 - 09:30 pm
Tags:
JNJ, Legend Biotech, CAR-T, FDA, Carvykti, Abecma
Asgard Gets $32M Series A Backing from J&J, Novo and Boehringer
BioSpace
Sun, 03/17/24 - 09:25 pm
Tags:
Asgard Therapeutics, JNJ, Novo Nordisk, Boehringer Ingelheim, funding, immuno-oncology
BMS’s Breyanzi Becomes First CAR-T Therapy for Two Types of Leukemia
BioSpace
Fri, 03/15/24 - 11:32 am
Tags:
Bristol Myers Squibb, CAR-T, CLL, Breyanzi, FDA, JNJ, Carvykti
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Tags:
Asgard Therapeutics, in vivo cell therapy, cell therapy, JNJ, Novo Nordisk
J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings
Fierce Pharma
Wed, 03/13/24 - 10:26 pm
Tags:
JNJ, Joaquin Duato, executive pay, Pharma CEOs
FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
Reuters
Wed, 03/13/24 - 10:46 am
Tags:
FDA, JNJ, Bristol Myers Squibb, blood cancers, cell therapy
Johnson & Johnson files sBLA for ulcerative colitis treatment
Pharmaceutical Business Review
Tue, 03/12/24 - 11:19 am
Tags:
JNJ, FDA, Tremfya, ulcerative colitis
J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis
BioSpace
Mon, 03/11/24 - 12:00 pm
Tags:
JNJ, clinical trials, JNJ-2113, psoriasis
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
Tags:
CAR-T, Multiple Myeloma, FDA, Bristol Myers Squibb, 2seventy bio, Abecma, JNJ, Legend Biotech, Carvykti

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.